Needham Reiterates Buy on Merit Medical Systems, Maintains $105 Price Target
Portfolio Pulse from Benzinga Newsdesk
Needham analyst Mike Matson has reiterated a Buy rating on Merit Medical Systems (NASDAQ:MMSI) and maintained a price target of $105.
September 16, 2024 | 12:07 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Needham analyst Mike Matson has reiterated a Buy rating on Merit Medical Systems and maintained a price target of $105, indicating confidence in the company's future performance.
The reiteration of a Buy rating and maintenance of a $105 price target by a reputable analyst suggests positive sentiment and confidence in Merit Medical Systems' future performance, likely leading to a short-term positive impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100